ISRG Bathi sing dikarepake Intuitive Surgical, Inc.

Regular maintenance of da Vinci systems and the sale of consumables provide Intuitive Surgical (ISRG) with a steady cash flow. The market trend for the price-to-earnings ratio is 4.33. Dominance in robotics and patent protection shut out competitors, while strict FDA oversight complicates entry into the niche. The developer's revenues depend on the volume of scheduled interventions, government equipment budgets, and the pace of physician training.

To verify the credit quality of Intuitive Surgical (ISRG), the analyst utilizes calculated future earnings dynamics, which filter out market noise and determine the fair trend through expected financial inflows. The steady growth of this indicator confirms the resilience of the business model, where the dominance of robotic systems and recurring payments for consumables minimize risks, protecting the investor from overpaying during local price peaks.